Protagonist Therapeutics, Inc.
PTGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $275 | -$79 | -$127 | -$126 |
| Dep. & Amort. | $3 | $3 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $38 | $29 | $24 | $16 |
| Change in WC | -$123 | -$20 | -$8 | -$3 |
| Other Non-Cash | -$9 | -$4 | -$1 | $2 |
| Operating Cash Flow | $184 | -$70 | -$108 | -$108 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | -$91 | $15 |
| Inv. Purchases | -$622 | -$191 | -$215 | -$287 |
| Inv. Sales/Matur. | $324 | $152 | $307 | $272 |
| Other Inv. Act. | $0 | $0 | $91 | -$15 |
| Investing Cash Flow | -$299 | -$39 | $91 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $26 | $132 | $15 | $124 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $38 | $4 | $6 |
| Financing Cash Flow | $26 | $170 | $19 | $130 |
| Forex Effect | $0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$89 | $61 | $2 | $6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $187 | $126 | $124 | $118 |
| End Cash | $97 | $187 | $126 | $124 |
| Free Cash Flow | $183 | -$71 | -$109 | -$109 |